April 25, 2019— President Trump’s ambitious campaign to end the HIV epidemic in the U.S. will rely heavily on the 340B drug pricing program, according to senior administration officials. A key focus of the effort is to connect people at risk of HIV infection to pre-exposure prophylaxis (PrEP), a treatment that can cost nearly $2,000 a month. In his State of the Union … [Read more...]
Busy times for 340B in Washington
November 19, 2018—The midterm elections were not the only source of Washington-related news in recent weeks with implications for the health care system. When it comes to 340B, several key events occurred in the days leading up to Election Day that might have longer-lasting implications for the program than the makeup of the 116th Congress. White House thinks globally on … [Read more...]
Death, Taxes…and Drug Price Increases
July 6, 2018—There’s new evidence that pharmaceutical manufacturers have not gotten the message that the Trump administration and the American public want an end to rising drug prices. Research documenting a host of drug price increases in June and July above the rate of inflation could complicate the Trump administration’s advocacy for its drug pricing blueprint, which … [Read more...]
What Does President Trump’s Drug Pricing Plan Mean for 340B?
May 11, 2018—While the 340B drug pricing program played a minor supporting role in President Trump’s drug pricing announcements today, it is certain to engender significant debate in the months ahead. The announcements made today no new policy proposals but did continue rhetorical attacks on the program. The President never uttered the words “340B” but did reference the … [Read more...]
Is Trump Budget DOA? What About 340B Changes?
Feb. 13, 2018—Washington, D.C., has many traditions. Cherry blossoms in Spring. Oppressive heat and humidity in Summer. School closings due to snow flurries in Winter. This week marked the latest installment of another: the release of the President’s budget blueprint for the coming year. On Monday, President Trump released what the White House has dubbed “An American Budget” … [Read more...]
Minnesota’s Largest Newspaper Explores How CMS Proposed Rule Would Hurt 340B Hospitals and Patients
September 25, 2017—Regulations proposed by the Trump administration could significantly weaken the 340B drug discount program, with programs for low-income or vulnerable patients taking the biggest hit, a 2013 Pulitzer Prize-winner writes in a front-page article in today’s Minneapolis Star-Tribune. … [Read more...]